Close Menu

Breaking News

These alterations, which can include hypermethylation of the H19 locus, can crop up during kidney development.

The funding comes about three years after Amgen provided the school with $1.5 million for a master's degree program in human genetics and genetic counseling.

Using pilot data from the GenomeAsia 100K Consortium, researchers searched for long, diverged haplotypes indicative of admixture between modern and archaic humans.

The German company reported its quarterly earnings for the first time as a public company, following the completion of its IPO on Nov. 7.

The firm plans to use the proceeds to fund operation and commercial growth as well as development of its Codex and Phenoptics spatial omics platforms.

The project has sequenced more than 1,700 individuals from across Asia to high coverage in order to bolster the representation of Asians in genomic research.

With the purchase, Canopy acquires Core's CLIA facility from which it will provide its multi-omic immune profiling services.

The grants were awarded through the organization's Diagnostic Accelerator, a partnership between the charity and various philanthropic partners.

The guidelines place a stronger emphasis on pancreatic cancer risk genes, and broaden testing recommendations for those with Ashkenazi Jewish ancestry.

The company is using the test to direct patient enrollment and treatment stratification in a trial of pembrolizumab (Keytruda) combination treatments.

The FDA approved FoundationOne CDx as a companion diagnostic for alpelisib in combination with fulvestrant to treat certain PIK3CA-mutated breast cancers.

The firms are combining Caris' somatic and Ambry's germline testing to provide clinicians with information on patients' cancers.

The Dutch companies will use sequencing- and machine learning-based methods to quantify genomic instability-causing mutations in blood cells.

Veracyte has also acquired Nanostring's Prosigna breast cancer and LymphMark lymphoma assays and plans to develop diagnostic tests using the nCounter platform. 

Illumina and PacBio wrote that the agency "has failed to establish that Illumina's short-read systems and PacBio's native long-read systems compete."

Members, spouses, and adult dependents from 13 locals will have access to Color's genomic services, including physician-ordered genetic tests.

The Human Protein Atlas was founded in 2003 to map all the human proteins in cells, tissues, and organs using a variety of omics technologies.

The LCD will provide coverage for the Decipher Prostate Biopsy genomic test for men with both favorable and unfavorable intermediate-risk prostate cancer. 

The clearance covers tests made by the firm's joint venture for manufacturing, CoSara Diagnostics, in its facility in Ranoli, India.

The researchers used the SomaScan platform to measure 5,000 plasma proteins across 17,000 patients and develop protein profiles correlated to 11 health conditions.

Working with MPEG-G booster GenomSys, SysMeta IT will integrate the new data compression specification into its Tangerine Medical platform to support clinicians.

ArcherDx will develop in vitro diagnostic tests, including companion diagnostics, to run on Illumina's NextSeq 550Dx next-generation sequencing system.

The platform matches a patient's medical history and other data with national guidelines to recommended medically actionable genetic tests.

The five-year FDA contract will add support for multi-omics data and various cloud-based analytical and statistical apps on the PrecisionFDA NGS platform.

The GenomeWeb Index outperformed the Dow Jones and the Nasdaq, but underperformed the Nasdaq Biotechnology Index this month.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.